Our response to study suggesting a comprehensive new method to predict breast cancer risk

New research published in journal Genetics in Medicine suggests that scientists have created the most comprehensive method to date to predict an...

15 January 2019

Perjeta approved in Scotland for secondary breast cancer

Discussing the news that the Scottish Medical Consortium (SMC) has approved pertuzumab (Perjeta) for use on NHS Scotland to treat secondary...

14 January 2019

We respond to approval of Perjeta for secondary breast cancer on NHS in Scotland

The Scottish Medicines Consortium (SMC) has announced its decision to approve life-extending drug Perjeta (pertuzumab) for routine use in treating...

14 January 2019

Our response to the publication of the NHS Long Term Plan

The Long Term Plan for the NHS in England has today (7 January 2019) been published by the Prime Minister, Rt Hon Theresa May MP, and the Chief...

7 January 2019

NHS Long Term Plan “barely scratches the surface” of huge challenges facing Health Service

Responding to the publication of the NHS Long Term Plan, Samia al Qadhi, Chief Executive of Breast Cancer Care, says: “This long-overdue...

7 January 2019

"Promising study" on protein treatment offers "fresh hope" to women with triple negative breast cancer

Discussing the results of testing Tinagl1, an experimental new protein treatment, on mice with triple negative breast cancer, Grete Brauten-Smith,...

4 January 2019

We respond to new figures showing uptake of NHS breast screening in England reaches new decade low

Provisional data on the Breast Screening Programme England for 2017-18 were published today by NHS Digital. The new figures revealed that breast...

20 December 2018

Uptake of routine breast screening invitations at "lowest level since current programme began"

Responding to NHS Digital data revealing that uptake of routine breast screening invitations amongst women aged 50-70 has fallen to 70.5% Addie...

20 December 2018

We respond to the withdrawal from market of a type of breast implant

The French regulatory body ANSM has announced that textured breast implants made by Allergan have been withdrawn from European markets as a result of...

20 December 2018